Literature DB >> 1616367

Aberrant cytokine production from tenosynovium in dialysis associated amyloidosis.

N Miyasaka1, K Sato, Y Kitano, M Higaki, K Nishioka, K Ohta.   

Abstract

Culture supernatants of tenosynovial tissues from patients with carpal tunnel syndrome undergoing chronic haemodialysis contained interleukin (IL) 1-like and IL6-like activity. These culture supernatants also induced active proliferation of rheumatoid synovial cells. Immunohistochemical analysis of teno-synovial tissues showed the accumulation of mononuclear cells bearing CD14 and HLA-DR antigens adjacent to the deposition of amyloid protein (beta 2 microglobulin). These cells also reacted with antibodies to IL1 and IL6 respectively. These data suggest that multiple cytokines, including IL1 and IL6, produced from tenosynovial tissues in patients with dialysis associated amyloidosis might induce the proliferation of synovial cells that, together with deposition of amyloid protein, might cause carpal tunnel syndrome.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1616367      PMCID: PMC1004750          DOI: 10.1136/ard.51.6.797

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  26 in total

1.  Carpal tunnel syndrome in patients on intermittent haemodialysis.

Authors:  D J Warren; L S Otieno
Journal:  Postgrad Med J       Date:  1975-07       Impact factor: 2.401

2.  Purification and partial sequence of human osteoclast-activating factor: identity with interleukin 1 beta.

Authors:  F E Dewhirst; P P Stashenko; J E Mole; T Tsurumachi
Journal:  J Immunol       Date:  1985-10       Impact factor: 5.422

3.  Preparation of lymphocyte-activating factor from continuous murine macrophage cell lines.

Authors:  L B Lachman; M P Hacker; G T Blyden; R E Handschumacher
Journal:  Cell Immunol       Date:  1977-12       Impact factor: 4.868

Review 4.  Interleukin-1 and its relevance in patients treated with hemodialysis.

Authors:  C A Dinarello; K M Koch; S Shaldon
Journal:  Kidney Int Suppl       Date:  1988-03       Impact factor: 10.545

5.  Interleukin 1, a potential regulator of fibroblast proliferation.

Authors:  J A Schmidt; S B Mizel; D Cohen; I Green
Journal:  J Immunol       Date:  1982-05       Impact factor: 5.422

6.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

Authors:  T Mosmann
Journal:  J Immunol Methods       Date:  1983-12-16       Impact factor: 2.303

7.  Beta 2-microglobulin: a new form of amyloid protein associated with chronic hemodialysis.

Authors:  F Gejyo; S Odani; T Yamada; N Honma; H Saito; Y Suzuki; Y Nakagawa; H Kobayashi; Y Maruyama; Y Hirasawa
Journal:  Kidney Int       Date:  1986-09       Impact factor: 10.612

8.  Beta-2 microglobulin is an amyloidogenic protein in man.

Authors:  P D Gorevic; T T Casey; W J Stone; C R DiRaimondo; F C Prelli; B Frangione
Journal:  J Clin Invest       Date:  1985-12       Impact factor: 14.808

9.  Localization of human mononuclear cell interleukin 1.

Authors:  P J Conlon; K H Grabstein; A Alpert; K S Prickett; T P Hopp; S Gillis
Journal:  J Immunol       Date:  1987-07-01       Impact factor: 5.422

10.  Interleukin 1 induces interleukin 1. I. Induction of circulating interleukin 1 in rabbits in vivo and in human mononuclear cells in vitro.

Authors:  C A Dinarello; T Ikejima; S J Warner; S F Orencole; G Lonnemann; J G Cannon; P Libby
Journal:  J Immunol       Date:  1987-09-15       Impact factor: 5.422

View more
  1 in total

1.  Increased matrix metalloproteinases as possible cause of osseoarticular tissue destruction in long-term haemodialysis and beta 2-microglobulin amyloidosis.

Authors:  K Ohashi; R Kawai; M Hara; Y Okada; S Tachibana; Y Ogura
Journal:  Virchows Arch       Date:  1996-04       Impact factor: 4.064

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.